AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
AH
Assort HealthAssort Health builds AI voice agents that automate patient access workflows for healthcare organizations, including scheduling, intake, referrals, and insurance verification.
2 Pulse stories
Total Raised
$222M
AEON BiopharmaAssort Health
Last Valuation
$1.2B
AEON BiopharmaAssort Health
Biotech
Sector
Biotech
2013
Founded
2023
Irvine, California
HQ
San Francisco, California
Public (AEON)
Status
Private
AEON Biopharma investors
No investors on record.
Assort Health investors
Menlo VenturesLightspeed Venture PartnersFelicisFirst Round CapitalChemistryLiquid 2 VenturesQuiet CapitalA* Capital
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and Assort Health.